Susanne Kolbe-Busch

Dr. Susanne Kolbe-Busch

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
SKSusanne Kolbe-Busch
Susanne Kolbe-Busch
PDPaule Dana DJOUELA DJOULAKO
Paule Dana DJOUELA DJOULAKO
Catalina-Suzana StinguCatalina-Suzana Stingu
Catalina-Suzana Stingu
Background: Healthcare-acquired infections due to multidrug-resistant organisms (MDR-HAIs) pose globally significant challenges to healthcare systems, leading to increased morbidity, mortality, and healthcare costs. According to the World Health Organization, the COVID-19 pandemic significantly impacted the burden of MDR-HAIs. The aim of this study was to investigate the dynamics and epidemiology of MDR-HAIs in inpatients at the University of Leipzig Medical Center (ULMC) before and during the COVID-19 pandemic. Methods: We compared data from inpatients with bacterial infections from 2017 to 2019 (pre-COVID-19) and from 2021to 2023 (during COVID-19) in a cross-sectional, monocentric, retrospective survey. This study focused on selected multidrug-resistant organisms (MDROs) and four clinical specimens. We analyzed the risk factors for MDR-HAIs using logistic regression models. Results: Out of 342,705 inpatients, 32,206 were diagnosed with a bacterial infection. The prevalence increased significantly from 8.09% (pre-COVID-19) to 10.79% (during COVID-19) (p < 0.001), but the proportion of MDROs decreased from 10.14% to 8.07%. The proportions of MDR-HAIs were 59.86% and 56.67%, respectively. The proportion of carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae increased significantly. The risk of MDR-HAIs during COVID-19 decreased by 18% compared to pre-COVID-19 (p = 0.047). Longer hospital stays increased the risk of MDR-HAIs in both periods. This risk significantly decreased for children and the elderly during COVID-19. Conclusion: These findings show that it is also important to analyze epidemiological data at the facility level in order to evaluate the effectiveness of infection control practices even during unprecedented health crises like the COVID-19 pandemic.

17 October 2024 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
TSTiffany Schaumburg
Tiffany Schaumburg
NKNorbert Köhler
Norbert Köhler
YBYasmine Breitenstein
Yasmine Breitenstein
SKSusanne Kolbe-Busch
Susanne Kolbe-Busch
DHDirk Hasenclever
Dirk Hasenclever
ICIris F. Chaberny
Iris F. Chaberny
Purpose Antiseptic bathing has garnered attention in an effort to reduce hospital-acquired infections. Previous studies have shown the efficacy of antiseptic bathing in high-risk environments, such as intensive care units (ICUs), using chlorhexidine. In this study we aimed to evaluate the effectiveness of octenidine as a potential alternative due to its established popularity and widespread use in Europe. Methods We compared the rates of ICU-acquired primary bacteremia and ICU-acquired multidrug-resistant organisms (MDROs) in a multicenter, cluster-randomized, double-blind, placebo-controlled, cross-over study using octenidine-impregnated and placebo washcloths. On 44 ICUs in 23 hospitals throughout Germany, we compared individual ICUs with themselves over two 12-month time periods. All data were obtained digitally via hospital information systems as individual ward-movement data and microbiological test results; both endpoints were algorithmically derived. Results 104,039 ICU episodes from 93,438 patients with 712,784 microbiological test results were analyzed, thereby detecting 1508 cases of ICU-acquired primary bacteremia and 1871 cases of ICU-acquired MDRO. Bathing with octenidine-impregnated washcloths prevented ICU-acquired primary bacteremia; a risk reduction of 17% was seen homogeneously across all participating ICUs (adjusted hazard ratio (HR) 0.83, 95% confidence interval (CI) [0.75; 0.92], p = 0.0003). This reduction affected predominantly coagulase-negative staphylococci (53%) and enterococci (17%). However, no intervention effect was seen for ICU-acquired MDROs (adjusted HR 0.98, 95% CI [0.83; 1.15]). Heterogeneity among intra-ICU intervention effects on MDRO acquisition was substantial. Conclusions Antiseptic bathing with octenidine may be effective in preventing ICU-acquired primary bacteremia, particularly due to Gram-positive bacteria and common skin commensals.

12 February 2024 in BMJ Open
Verified
Journal Article
Open access
VKValentine Keil
Valentine Keil
TSTiffany Schaumburg
Tiffany Schaumburg
FBFrederike Buchta
Frederike Buchta
JLJ Katrin Luz
J Katrin Luz
SKSusanne Kolbe-Busch
Susanne Kolbe-Busch
TLThomas von Lengerke
Thomas von Lengerke
Introduction: Infection prevention and control (IPC) teams are routinely confronted with intense emotions in their daily work, as they are involved in many change processes with front-line medical staff, for example, when promoting compliance with basic IPC measures. In addition, they are confronted with challenges due to their role as intermediaries. Based on former research, this study aims to empower IPC teams to promote clinicians’ compliance through interventions focusing on the IPC teams’ leadership skills. Methods and analysis: The IP-POWER study (Infection Prevention with head and heart: Psychological empowerment of IPC teams), a multicentre, two-arm, non-blinded, cluster-randomised controlled trial with a parallel waiting control group, is planned to be conducted in Germany as of February to November 2024. A group of 10 voluntary hospitals is going to participate in a multistage intervention programme, including 2 days of intense psychological training; 5 hospitals will be randomly assigned to the waiting control group. After the workshops, there will be a 12-week follow-up period during which the contents learnt within the workshops can be applied and internalised into IPC practice. The proposed outcomes (both self-assessed and other-assessed leadership competencies of IPC team members and their task profiles, perceived workload, motivation to act in order to implement IP measures and goal attainment) are going to be collected with an online questionnaire, followed by an analysis with IBM SPSS (Statistics 29 (or later)) using descriptive analyses and multiple linear regressions. Additionally, as external data sources, hand hygiene compliance rates from the study hospitals’ monitoring systems will be analysed using χ² tests. Ethics and dissemination: This study was reviewed and approved by the ethics committee of the University of Leipzig (184/23-ek; vote from 4 July 2023). Findings will be disseminated via peer-review publications, and national and international conference presentations. Trial registration number: DRKS00031879.

24 March 2025 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
TSTiffany Schaumburg
Tiffany Schaumburg
NKNorbert Köhler
Norbert Köhler
YBYasmine Breitenstein
Yasmine Breitenstein
SKSusanne Kolbe-Busch
Susanne Kolbe-Busch
DHDirk Hasenclever
Dirk Hasenclever
ICIris F. Chaberny
Iris F. Chaberny
51" though it should correctly be "351".

8 October 2026 in Eurosurveillance
Verified
Journal Article
Open access
SBSofia Burdi
Sofia Burdi
LHLukas Herrmann
Lukas Herrmann
SKSophia N. Koerdt
Sophia N. Koerdt
SWSilver A. Wolf
Silver A. Wolf
SASandra Appelt
Sandra Appelt
SHSebastain Haller
Sebastain Haller
A nosocomial outbreak of Ralstonia mannitolilytica bloodstream infections in Germany from March to September 2026 included 16 cases (≤ 6 allelic differences using core genome multilocus sequence typing) across seven hospitals. Epidemiological investigations supported by a large language model, identified prefilled saline flush syringes of one manufacturer as common exposure across all cases. The manufacturer initiated a temporary quarantine and suspension of use of this product. Because it was distributed to other countries, cases may have occurred elsewhere, prompting this report.

2 January 2023 in Die Chirurgie
Verified
Journal Article
Closed access
PDF file
SKSusanne Kolbe-Busch
Susanne Kolbe-Busch
ICIris F. Chaberny
Iris F. Chaberny